ES2279542T3 - Mutantes de hbv y metodos para deteccion de los mismos. - Google Patents

Mutantes de hbv y metodos para deteccion de los mismos. Download PDF

Info

Publication number
ES2279542T3
ES2279542T3 ES97934385T ES97934385T ES2279542T3 ES 2279542 T3 ES2279542 T3 ES 2279542T3 ES 97934385 T ES97934385 T ES 97934385T ES 97934385 T ES97934385 T ES 97934385T ES 2279542 T3 ES2279542 T3 ES 2279542T3
Authority
ES
Spain
Prior art keywords
baselineskip
hbv
xaa
leu
variante
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97934385T
Other languages
English (en)
Spanish (es)
Inventor
Stephen Alister Locarnini
Angeline Ingrid Bartholomeusz
Thein Thein Aye
Robert A. De Man
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Melbourne Health
Original Assignee
Melbourne Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melbourne Health filed Critical Melbourne Health
Application granted granted Critical
Publication of ES2279542T3 publication Critical patent/ES2279542T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES97934385T 1996-11-08 1997-08-15 Mutantes de hbv y metodos para deteccion de los mismos. Expired - Lifetime ES2279542T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPO3519/96 1996-11-08
AUPO3519A AUPO351996A0 (en) 1996-11-08 1996-11-08 Viral variants and methods for detecting same

Publications (1)

Publication Number Publication Date
ES2279542T3 true ES2279542T3 (es) 2007-08-16

Family

ID=3797830

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97934385T Expired - Lifetime ES2279542T3 (es) 1996-11-08 1997-08-15 Mutantes de hbv y metodos para deteccion de los mismos.

Country Status (9)

Country Link
US (4) US6555311B1 (enExample)
EP (1) EP0964916B1 (enExample)
JP (4) JP2001503277A (enExample)
AT (1) ATE348880T1 (enExample)
AU (1) AUPO351996A0 (enExample)
CA (1) CA2270178C (enExample)
DE (1) DE69737126T2 (enExample)
ES (1) ES2279542T3 (enExample)
WO (1) WO1998021317A1 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA973367B (en) 1996-04-19 1997-11-18 Innogenetics Nv Method for typing and detecting HBV.
USRE40233E1 (en) 1996-11-08 2008-04-08 Melbourne Health Viral variants and methods for detecting same
AUPO351996A0 (en) * 1996-11-08 1996-12-05 Western Health Care Network Viral variants and methods for detecting same
AUPP706098A0 (en) * 1998-11-11 1998-12-03 North Western Health Care Network Biological compositions, components thereof and uses therefor
AUPP967999A0 (en) * 1999-04-09 1999-05-06 North Western Health Care Network Viral variants
AR028149A1 (es) * 1999-07-08 2003-04-30 Innogenetics Nv Deteccion de la resistencia a los farmacos contra la hepatitis b
AUPQ810900A0 (en) 2000-06-09 2000-07-06 Austin and Repatriation Medical Centre, The Viral variants and methods of using same
SG90149A1 (en) * 2000-07-18 2002-07-23 Government Of The Republic Of Diagnostic assay
US6697858B1 (en) * 2000-08-14 2004-02-24 Telephony@Work Call center
US7405039B2 (en) 2002-02-07 2008-07-29 Austin Health Viral variants with altered susceptibility to nucleoside analogs and uses thereof
JP4502642B2 (ja) * 2002-02-07 2010-07-14 メルボルン ヘルス ヌクレオシドアナログに対する感受性の変化を有するウイルス変種およびその使用
AU2002308114A1 (en) 2002-03-29 2003-10-13 Innogenetics N.V. Hbv drug resistance drug resistance detection methods
AU2003213874B2 (en) * 2002-04-12 2008-12-04 Austin Health Hepatitis B viral variants with redused susceptibility to nucleoside analogs and uses thereof
EP2033967A1 (en) 2002-04-12 2009-03-11 Melbourne Health Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
EP2292801B1 (en) 2002-06-14 2018-08-08 Gen-Probe Incorporated Compositions and methods for detecting hepatitis b virus
US20050053916A1 (en) * 2002-10-01 2005-03-10 Korba Brent E. Diagnostic for long term response of HBV carrier to 3TC therapy
WO2006097285A1 (en) 2005-03-15 2006-09-21 Innogenetics N.V. Hepatitis-b viral variants with reduced susceptibility to nucleoside analogs and uses thereof
ES2470318T3 (es) 2005-03-15 2014-06-23 Rheinische Friedrich-Wilhelms-Universit�T Bonn Variantes del virus de la hepatitis B resistentes a ciertos análogos nucle�sidos, pero sensibles a otros, y usos de las mismas
US8211443B2 (en) 2005-04-08 2012-07-03 Melbourne Health Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
EP1874923A4 (en) 2005-04-08 2010-08-04 Melbourne Health VARIANTS OF THE HEPATITIS B VIRUS WITH RESISTANCE TO ANTIVIRAL NUCLEOSIDAGENTS AND APPLICATIONS THEREOF
KR100790226B1 (ko) 2005-11-03 2008-01-02 연세대학교 산학협력단 독성 간염 유발 감수성을 검출하는 방법
US20230148447A9 (en) 2008-12-11 2023-05-11 Pacific Biosciences Of California, Inc. Classification of nucleic acid templates
US9175338B2 (en) * 2008-12-11 2015-11-03 Pacific Biosciences Of California, Inc. Methods for identifying nucleic acid modifications
EP2370598B1 (en) * 2008-12-11 2017-02-15 Pacific Biosciences Of California, Inc. Classification of nucleic acid templates
US9611510B2 (en) 2011-04-06 2017-04-04 The University Of Chicago Composition and methods related to modification of 5-methylcytosine (5-mC)
US9238836B2 (en) 2012-03-30 2016-01-19 Pacific Biosciences Of California, Inc. Methods and compositions for sequencing modified nucleic acids
US9175348B2 (en) 2012-04-24 2015-11-03 Pacific Biosciences Of California, Inc. Identification of 5-methyl-C in nucleic acid templates
CN115003685A (zh) * 2019-12-07 2022-09-02 Isa制药有限公司 乙型肝炎病毒相关疾病的治疗
CN115561456B (zh) * 2021-07-01 2025-10-31 黄温雅 体外定量b肝病毒大表面蛋白的套组以及用于处理肝病的生物指标组及单株抗体组

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595739A (en) * 1993-05-07 1997-01-21 Abbott Laboratories Hepatitis B virus mutants, reagents and methods for detection
ZA973367B (en) * 1996-04-19 1997-11-18 Innogenetics Nv Method for typing and detecting HBV.
USRE40233E1 (en) * 1996-11-08 2008-04-08 Melbourne Health Viral variants and methods for detecting same
AUPO351996A0 (en) * 1996-11-08 1996-12-05 Western Health Care Network Viral variants and methods for detecting same
AUPP967999A0 (en) * 1999-04-09 1999-05-06 North Western Health Care Network Viral variants
AUPQ810900A0 (en) * 2000-06-09 2000-07-06 Austin and Repatriation Medical Centre, The Viral variants and methods of using same
US7405039B2 (en) * 2002-02-07 2008-07-29 Austin Health Viral variants with altered susceptibility to nucleoside analogs and uses thereof
AU2002308114A1 (en) * 2002-03-29 2003-10-13 Innogenetics N.V. Hbv drug resistance drug resistance detection methods
EP2033967A1 (en) * 2002-04-12 2009-03-11 Melbourne Health Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
JP2007509614A (ja) * 2003-10-21 2007-04-19 メルボルン ヘルス Ｈｂｖ変種の検出および適用
ES2470318T3 (es) * 2005-03-15 2014-06-23 Rheinische Friedrich-Wilhelms-Universit�T Bonn Variantes del virus de la hepatitis B resistentes a ciertos análogos nucle�sidos, pero sensibles a otros, y usos de las mismas
WO2006097285A1 (en) * 2005-03-15 2006-09-21 Innogenetics N.V. Hepatitis-b viral variants with reduced susceptibility to nucleoside analogs and uses thereof
EP1874923A4 (en) * 2005-04-08 2010-08-04 Melbourne Health VARIANTS OF THE HEPATITIS B VIRUS WITH RESISTANCE TO ANTIVIRAL NUCLEOSIDAGENTS AND APPLICATIONS THEREOF
US8211443B2 (en) * 2005-04-08 2012-07-03 Melbourne Health Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
CN101548014B (zh) * 2006-06-06 2012-07-04 墨尔本保健公司 抗病毒抗性突变的检测和应用

Also Published As

Publication number Publication date
EP0964916B1 (en) 2006-12-20
US6555311B1 (en) 2003-04-29
JP2015107127A (ja) 2015-06-11
EP0964916A4 (en) 2001-09-26
CA2270178A1 (en) 1998-05-22
EP0964916A1 (en) 1999-12-22
CA2270178C (en) 2012-06-12
WO1998021317A1 (en) 1998-05-22
US20030124096A1 (en) 2003-07-03
JP2012055322A (ja) 2012-03-22
AUPO351996A0 (en) 1996-12-05
US20130171620A1 (en) 2013-07-04
DE69737126T2 (de) 2007-10-04
HK1027374A1 (en) 2001-01-12
JP2001503277A (ja) 2001-03-13
ATE348880T1 (de) 2007-01-15
JP2008154590A (ja) 2008-07-10
DE69737126D1 (de) 2007-02-01
US20100203506A1 (en) 2010-08-12

Similar Documents

Publication Publication Date Title
ES2279542T3 (es) Mutantes de hbv y metodos para deteccion de los mismos.
Pawlotsky The concept of hepatitis B virus mutant escape
Hunt et al. Clinical relevance of hepatitis B viral mutations
Locarnini et al. Cellular and virological mechanisms of HBV drug resistance
US7931907B2 (en) Hepatitis B virus DNA polymerase and surface antigen variants and methods of using same
Bock et al. Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation
Tillmann et al. Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation
ES2204912T3 (es) Peptidos que inducen respuestas de linfoccitos t citotoxicos contra el virus de la hepatitis b.
AU734831C (en) Viral variants and methods for detecting same
USRE40233E1 (en) Viral variants and methods for detecting same
Foster et al. Replication of hepatitis B and delta viruses: appearance of viral mutants
Petzold et al. Infection chains and evolution rates of hepatitis B virus in cardiac transplant recipients infected nosocomially
AU780978B2 (en) Viral variants and methods for detecting same
HK1027374B (en) Hbv mutants and methods for detecting same
AU2001263672B2 (en) Hepatitis B virus DNA polymerase and surface antigen variants and methods of using same
Kim et al. Mutations in the pre-core region of hepatitis B virus DNA in patients with chronic liver diseases
Bhise HBV Polymerase as a Target for Development of Anti-HBV Drugs
Jazayeri Hepatitis B core evolution and cellular localisation
HK1053144B (en) Hepatitis b virus dna polymerase and surface antigen variants and methods of using same
HK1161617A (en) Hepatitis b virus dna polymerase and surface antigen variants and methods of using same
Colacino Drug discovery and development of anti-viral agents for the
AU2001263672A1 (en) Hepatitis B virus DNA polymerase and surface antigen variants and methods of using same
Yuan Characterization of naturally occurring mutations in the precore and core genes of hepatitis B virus